PET Scan and Sarcoidosis: What the Results Can Mean

Sarcoidosis is an inflammatory condition in which clusters of immune cells can form in organs such as the lungs, lymph nodes, skin, eyes, or heart. The FDG radiotracer used for many PET scans collects in cells with increased activity. This means inflamed sarcoidosis tissue may look bright on the scan, much as some tumours do.

The PET part shows areas using more tracer, while the CT part shows their location and appearance. A pattern involving both sides of the chest, several lymph-node groups, or known sites of sarcoidosis may support inflammation, but patterns overlap with lymphoma and other cancers. The scan is therefore interpreted alongside your symptoms, examination, previous images, blood tests, and any tissue sample.

A bright area does not prove cancer, and a less active area does not exclude every problem. Treatment for sarcoidosis can also change the amount of inflammation visible on a scan. If the scan is being used to assess possible heart involvement, preparation and the type of cardiac imaging matter because normal heart muscle takes up glucose naturally.

A PET-CT may help show where active disease is located, guide the choice of a biopsy site, or help a specialist assess whether inflammation is responding to treatment. It does not replace tissue diagnosis when the clinical question is whether a lesion is cancer.

Read the report with the clinician who ordered the scan, because the wording is only meaningful in the context of why the scan was requested. Bring earlier CT, X-ray, MRI, or PET reports if they were performed elsewhere. Tell the imaging team about sarcoidosis, recent infections, steroid or other anti-inflammatory treatment, diabetes, pregnancy or possible pregnancy, and any difficulty following fasting instructions.

The next step may be comparison with older images, a different scan, laboratory assessment, specialist review, or a biopsy. Do not stop prescribed treatment based only on the PET result. If a biopsy is suggested, ask which site is safest and how the result would change the treatment plan.

Contact your treating team promptly if you develop worsening breathlessness, chest pain, fainting, a new fast or irregular heartbeat, sudden weakness, or a marked change in vision. These symptoms can have causes unrelated to the scan, but they need timely clinical assessment, particularly when sarcoidosis may involve the heart, lungs, nervous system, or eyes.

Seek emergency help for severe trouble breathing, severe chest pressure, loss of consciousness, or sudden one-sided weakness. A PET finding alone does not determine how urgent your situation is; your current symptoms do.

Ask: Which areas showed FDG uptake, and what did the CT component show there? Could the pattern fit sarcoidosis, infection, cancer, or more than one process? Do I need comparison with an earlier scan or another type of imaging? Is a biopsy needed, and which location would provide the clearest answer with the least risk? If heart involvement is a concern, do I need dedicated cardiac testing? When will we review the report and decide on follow-up?